June 2023. Volume 19. Number 2

The risk of myocarditis after SARS-CoV-2 vaccination, is it acceptable?

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Naveed Z, Li J, Spencer M, Wilton J, Naus M, Velásquez García HA, et al. Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study. CMAJ. 2022;194:E1529-36.

Reviewers: Lemos Bouzas MX1, Esparza Olcina MJ2.
1Hospital Álvaro Cunqueiro. Vigo. Pontevedra. España.
2Pediatra de Atención Primaria. Madrid. España.
Correspondence: M.ª Xesús Lemos Bouzas . Email: maria.xesus.lemos.bouzas@sergas.es
Reception date: 19/02/2023
Acceptance date: 30/05/2023
Publication date: 07/06/2023

Abstract

Authors’ conclusions: although mRNA-vaccination against COVID-19 does seem to increase the myocarditis rates, the benefits of this immunization still overrate the risk of presenting myocarditis after vaccination.

Reviewers’ commentary: the risk-benefit balance favors vaccination. Nevertheless, close monitoring and record of adverse events must be continued.

How to cite this article

Lemos Bouzas MX, Esparza Olcina MJ. El riesgo de miocarditis tras la vacunación contra el SARS-CoV-2, ¿es aceptable? Evid Pediatr. 2023;19:19.

AVC | Critically appraised articles

Naveed Z, Li J, Spencer M, Wilton J, Naus M, Velásquez García HA, et al. Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study. CMAJ. 2022;194:E1529-36.

Reviewers: Lemos Bouzas MX1, Esparza Olcina MJ2.
1Hospital Álvaro Cunqueiro. Vigo. Pontevedra. España.
2Pediatra de Atención Primaria. Madrid. España.
Correspondence: M.ª Xesús Lemos Bouzas . Email: maria.xesus.lemos.bouzas@sergas.es
Reception date: 19/02/2023
Acceptance date: 30/05/2023
Publication date: 07/06/2023

How to cite this article

Lemos Bouzas MX, Esparza Olcina MJ. El riesgo de miocarditis tras la vacunación contra el SARS-CoV-2, ¿es aceptable? Evid Pediatr. 2023;19:19.

07/06/2023

Linked Comment